New class of drug shows promise for treating asthma and COPD

Scientists have developed a new drug (RPL554) that could treat obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD) in two ways at once, according to new research published in The Lancet Respiratory Medicine. RPL554 has the potential to both reverse the narrowing of the airways (bronchodilation) and reduce inflammation quicker and with fewer side effects than current therapies.....

Read more here: yottafire.com

------------------------------------------------------

Asthma Field Reimbursement Account Manager (AFRM) - Kansas/Missouri

Who We Are
At the Roche Group, about 80,000 people across 150 countries are pushing back the frontiers of healthcare. Working together, we've become one of the world's leading research-focused healthcare groups. A member of the Roche Group, Genentech has been at the forefront of the biotechnology industry for more than 30 years, using human genetic information to develop novel medicines for serious and life-threatening diseases.....

Read more here: gene.com

------------------------------------------------------

Treatments for Asthma

You and your doctor will create an asthma action plan. This is a plan you will follow to help control your asthma and handle asthma attacks. Medications and lifestyle changes are the mainstay of asthma treatment.....

Read more here: skylinemedicalgroup.com